Overview: Alanine Aminotransferase TestIntroduction: The Alanine Aminotransferase Test measures ALT to diagnose liver disease, causing fatigue or abdominal pain. Following 2023 AASLD guidelines, it uses biochemical methods for high specificity, supporting liver screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected liver disorders.
Other Names: SGPT Assay, ALT Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: ALT testing began in the 1950s with liver enzyme research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures ALT to diagnose liver disease, guides treatment, and evaluates patients with fatigue or abdominal pain.
Test Parameters: 1. ALT Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of fatigue, abdominal pain, or liver symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, abdominal pain, or history of liver disorders. Include current medications, especially hepatotoxic drugs.
Consent: Written consent required, detailing the tests purpose, liver disease implications, and risks of sample collection.
Procedural Considerations: Uses enzymatic assays to measure ALT levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for liver disease diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Alcohol or medications may elevate ALT levels.
Clinical Significance: Elevated ALT confirms liver disease, guiding hepatoprotective therapies. Normal levels may require GGT or imaging.
Specialist Consultation: Consult a hepatologist for result interpretation and treatment planning.
Additional Supporting Tests: AST, GGT, or liver ultrasound to confirm liver disease diagnosis.
Test Limitations: Non-specific for certain liver conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: AASLD Liver Guidelines, 2023; Clinical Chemistry, Kwo PY, 2022.
